Vergent Bioscience

aid: vergent-bioscience
name: Vergent Bioscience
description: Vergent Bioscience is a clinical-stage biotechnology company headquartered in Minneapolis, Minnesota, developing
  tumor-targeted fluorescent imaging agents for real-time intraoperative tumor visualization. Its lead compound, abenacianine
  for injection (VGT-309), is designed to let surgeons see previously undetected or difficult-to-find tumors during minimally
  invasive and robotic-assisted cancer surgery so that all tumor tissue can be removed in a single procedure. The company
  is first evaluating VGT-309 in lung cancer with the stated intent to expand into a wide range of solid tumors. Vergent publishes
  no developer program, no REST or GraphQL API, and no SDKs — it is a therapeutics and imaging-agent developer, not a software
  vendor. The only machine-readable surfaces on its own domain are a Wix-platform-generated llms.txt and a live, anonymous
  Model Context Protocol endpoint at /_api/mcp that exposes nine site-content and Wix-platform tools.
url: https://raw.githubusercontent.com/api-evangelist/vergent-bioscience/refs/heads/main/apis.yml
image: https://static.wixstatic.com/media/608efe_20a2e114600643b69837255747a0ffe5~mv2.jpg
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment
specificationVersion: '0.20'
created: '2026-09-02'
modified: '2026-09-02'
tags:
- Company
- Biotechnology
- Life Sciences
- Healthcare
- Medical Imaging
- Oncology
- Surgery
- Clinical Trials
- Model Context Protocol
apis:
- name: Vergent Bioscience Site MCP
  description: A live, anonymous Model Context Protocol endpoint served on the company's own host and advertised from its
    own llms.txt. Provided by the Wix Site MCP platform rather than authored by Vergent, it exposes nine tools — site content
    search, business details, Wix documentation lookups, anonymous visitor-token issuance, and two generic Wix REST API passthroughs.
    A tools/list probe on 2026-09-02 returned HTTP 200 with full JSON Schema input schemas and required no credentials.
  humanURL: https://www.vergentbio.com/llms.txt
  baseURL: https://www.vergentbio.com/_api/mcp
  tags:
  - Model Context Protocol
  - Site Content
  properties:
  - type: MCPServer
    url: mcp/vergent-bioscience-mcp.yml
  - type: Authentication
    url: authentication/vergent-bioscience-authentication.yml
  - type: Conventions
    url: conventions/vergent-bioscience-conventions.yml
  - type: RateLimits
    url: rate-limits/vergent-bioscience-rate-limits.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/vergent-bioscience-domain-security.yml
- type: Website
  url: https://www.vergentbio.com/
- type: LLMsTxt
  url: llms/vergent-bioscience-llms.txt
- type: Conformance
  url: conformance/vergent-bioscience-conformance.yml
- type: Plans
  url: plans/vergent-bioscience-plans-pricing.yml
- type: Support
  url: https://www.vergentbio.com/contact
- type: TermsOfService
  url: https://www.vergentbio.com/terms
- type: PrivacyPolicy
  url: https://www.vergentbio.com/privacy
x-enrichment:
  date: '2026-09-02'
  status: enriched
  artifacts_added: 10
  pass: local-v1
x-coverage:
  state: covered
  reason: null
  detail: 'Vergent Bioscience is a clinical-stage biotech with no developer program, but STEP 0b contract discovery found
    two real machine-readable surfaces on its own host: a Wix-generated /llms.txt (HTTP 200, 3458 bytes) and a live anonymous
    MCP endpoint at /_api/mcp whose tools/list returned HTTP 200 with 9 schema-bearing tools. No OpenAPI, GraphQL, AsyncAPI,
    .proto or WSDL exists on any company host.'
  evidence:
  - url: https://www.vergentbio.com/llms.txt
    status: 200
  - url: https://www.vergentbio.com/_api/mcp
    status: 200
  - url: https://www.vergentbio.com/openapi.json
    status: 400
  - url: https://www.vergentbio.com/.well-known/agent-card.json
    status: 400
  checked: '2026-09-02'